High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia

The Brief Psychiatric Rating Scale

1962 • 10,683 citations

ECDEU Assessment Manual for Psychopharmacology

1976 • 8,729 citations

A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS

1970 • 3,213 citations

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans

1994 • 3,182 citations

Glycine potentiates the NMDA response in cultured mouse brain neurons

1987 • 3,116 citations

Psychopharmacology: The Fourth Generation of Progress

1995 • 2,920 citations

Recent advances in the phencyclidine model of schizophrenia

1991 • 2,886 citations

Psychopharmacology: The Fourth Generation of Progress

1995 • 1,676 citations

Requirement for Glycine in Activation of NMDA-Receptors Expressed in Xenopus Oocytes

1988 • 1,415 citations

Study of a New Schizophrenomimetic Drug—Sernyl

1959 • 922 citations

Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia

1995 • 891 citations

D-Alanine Added to Antipsychotics for the Treatment of Schizophrenia

2005 • 670 citations

Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics

1997 • 670 citations

NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers

1996 • 667 citations

Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications.

1998 • 621 citations

D-serine added to antipsychotics for the treatment of schizophrenia

1998 • 557 citations

Efficacy of High-Dose Glycine in the Treatment of Enduring Negative Symptoms of Schizophrenia

1999 • 484 citations

Abnormal Excitatory Neurotransmitter Metabolism in Schizophrenic Brains

1995 • 458 citations

A Placebo-Controlled Trial of D-Cycloserine Added to Conventional Neuroleptics in Patients With Schizophrenia

1999 • 435 citations

Schizophrenia and Glutamatergic Transmission

1998 • 385 citations

Neuropharmacological Mechanisms of Drug Reward: Beyond Dopamine in the Nucleus Accumbens

1998 • 382 citations

Amelioration of negative symptoms in schizophrenia by glycine

1994 • 349 citations

A “Glutamatergic Hypothesis” of Schizophrenia

1989 • 270 citations

Five-Factor Model of Schizophrenia Initial Validation

1994 • 255 citations

Double-Blind, Placebo-Controlled, Crossover Trial of Glycine Adjuvant Therapy for Treatment-Resistant Schizophrenia

1996 • 253 citations

Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia

1995 • 238 citations

Developmental Changes in NMDA Receptor Glycine Affinity and Ifenprodil Sensitivity Reveal Three Distinct Populations of NMDA Receptors in Individual Rat Cortical Neurons

1998 • 229 citations

<scp>d-</scp>Serine Added to Clozapine for the Treatment of Schizophrenia

1999 • 224 citations

Biological Psychiatry

2002 • 214 citations

A placebo-controlled crossover trial of d-cycloserine added to clozapine in patients with schizophrenia

1999 • 179 citations

A Double-Blind Comparative Study of Clozapine and Risperidone in the Management of Severe Chronic Schizophrenia

2001 • 174 citations

Placebo-Controlled Trial of Glycine Added to Clozapine in Schizophrenia

2000 • 174 citations

Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys.

1999 • 156 citations

Risperidone in Treatment-Refractory Schizophrenia

1999 • 149 citations

Effect of Clozapine and Adjunctive High-Dose Glycine in Treatment-Resistant Schizophrenia

1999 • 140 citations

Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response

1999 • 123 citations

Glycine Adjuvant Therapy to Conventional Neuroleptic Treatment in Schizophrenia

1989 • 104 citations

Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors

1999 • 99 citations

Antagonism of phencyclidine-induced hyperactivity by glycine in mice

1986 • 94 citations

Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial

1996 • 91 citations

NR2B Selective NMDA Receptor Antagonists

2002 • 89 citations

d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study

1994 • 88 citations

Cerebrospinal fluid amino acid concentrations in chronic schizophrenia

1987 • 76 citations

Glycine Site Agonists of the NMDA Receptor: A Review

1995 • 57 citations

Glycine Therapy in 7 Cases of Spasticity

1974 • 25 citations

Die Glykokollbehandlung der progressiven Muskeldystrophie¹

1933 • 7 citations